Daisy Foundation Report issue

Foundation Phase 1

Organization Overview

First Clinical Trial
2014
NCT02441075
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Daisy Foundation